Live Breaking News & Updates on நோவர்த்திச் தலைமை சட்டப்பூர்வமானது அதிகாரி

Stay updated with breaking news from நோவர்த்திச் தலைமை சட்டப்பூர்வமானது அதிகாரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novartis Pharma AG: Novartis announces change to the Executive Committee

Novartis Pharma AG: Novartis announces change to the Executive Committee
Thomas Kendris appointed Chief Legal Officer ad interim
Basel, March 5, 2021 - Novartis announced today that Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company. Ms. Klinger will step down from the Executive Committee of Novartis (ECN), effective March 15, 2021.
Thomas N. Kendris, currently Global Head Litigation and US Country President, will be appointed Chief Legal Officer ad interim and attendee to the ECN in this capacity. Novartis has started an executive search process to evaluate internal and external candidates for the role of its Chief Legal Officer. ....

United States , Richard Jarvis , Isabella Zinck , Thomas Hungerbuehler , Thomasn Kendris , Thomas Kendris , Samir Shah , Julie Masow , Sloan Simpson , Tom Kendris , Shannon Klinger , Exchange Commission , Novartis Group , Us Pharma At Novartis Pharmaceuticals Corporation , Committee Of Novartis , Chief Legal Officer , Shannon Thyme Klinger , Executive Committee , Global Head Litigation , Chief Legal , Global Head , Vice President , General Counsel , Novartis Pharmaceuticals Corporation , Global General Counsel , Novartis Oncology ,

Novartis announces change to the Executive Committee

Thomas Kendris appointed Chief Legal Officer ad interim
Basel, March 5, 2021 Novartis announced today that Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company. Ms. Klinger will step down from the Executive Committee of Novartis (ECN), effective March 15, 2021.
Thomas N. Kendris, currently Global Head Litigation and US Country President, will be appointed Chief Legal Officer ad interim and attendee to the ECN in this capacity. Novartis has started an executive search process to evaluate internal and external candidates for the role of its Chief Legal Officer. ....

United States , Richard Jarvis , Isabella Zinck , Thomas Hungerbuehler , Thomasn Kendris , Thomas Kendris , Samir Shah , Julie Masow , Sloan Simpson , Tom Kendris , Shannon Klinger , Exchange Commission , Novartis Group , Us Pharma At Novartis Pharmaceuticals Corporation , Committee Of Novartis , Chief Legal Officer , Shannon Thyme Klinger , Executive Committee , Global Head Litigation , Chief Legal , Global Head , Vice President , General Counsel , Novartis Pharmaceuticals Corporation , Global General Counsel , Novartis Oncology ,